Research Topics
Species | Martin SteinbergSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Atypical antipsychotic use in patients with dementia: managing safety concernsMartin Steinberg
Johns Hopkins Bayview Medical Center, Baltimore, USA
Am J Psychiatry 169:900-6. 2012..Through careful selection of appropriate patients for treatment, education of patients and caregivers, and close monitoring, safety risks can be minimized...
Risk factors for neuropsychiatric symptoms in dementia: the Cache County StudyM Steinberg
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Int J Geriatr Psychiatry 21:824-30. 2006..To investigate the probability of individual neuropsychiatric symptoms in dementia patients as a function of eight risk factors...- Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS studyMartin Steinberg
Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Int J Geriatr Psychiatry 19:144-50. 2004..To investigate patient predictors of response to treatment of Major Depressive Episode (MDE) in Alzheimer's disease (AD)... - The persistence of neuropsychiatric symptoms in dementia: the Cache County StudyMartin Steinberg
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Int J Geriatr Psychiatry 19:19-26. 2004..To estimate the 18-month persistence of neuropsychiatric symptoms in dementia in a population-based sample, and to compare the severity of neuropsychiatric symptoms at baseline to the severity at 18-month follow-up... - Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County StudyMartin Steinberg
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Int J Geriatr Psychiatry 23:170-7. 2008..Neuropsychiatric symptoms are nearly universal in dementia, yet little is known about their longitudinal course in the community... 
Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) studyMartin Steinberg
John Hopkins Bayview Medical Center, Baltimore, MD, USA
Int J Geriatr Psychiatry 24:680-5. 2009..To determine the feasibility and efficacy of a home-based exercise intervention program to improve the functional performance of patients with Alzheimer's Disease (AD)...- The incidence of mental and behavioral disturbances in dementia: the cache county studyMartin Steinberg
Johns Hopkins Hospital, Baltimore, MD 21287, USA
J Neuropsychiatry Clin Neurosci 15:340-5. 2003..These results argue for a routine assessment of psychiatric disturbances in all patients with dementia, even among those who have never experienced symptoms of mental or behavioral disturbances... - Epidemiology of apathy in older adults: the Cache County StudyChiadi U Onyike
Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
Am J Geriatr Psychiatry 15:365-75. 2007..The objectives of this study are to describe the distribution of apathy in community-based older adults and to investigate its relationships with cognition and day-to-day functioning... - Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County StudyMatthew E Peters
The Johns Hopkins University, Baltimore, MD, USA
Am J Geriatr Psychiatry 20:416-24. 2012..2) To compare the 30-day prevalence of NPS in CIND with that in dementia and cognitively normal individuals. 3) To compare the prevalence of NPS in amnestic MCI (aMCI) with other predementia syndromes... - Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS)Cynthia A Munro
Division of Medical Psychology, Department of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Baltimore, MD, USA
Am J Geriatr Psychiatry 12:491-8. 2004..The authors assessed the cognitive effects of depression treatment with sertraline in patients with Alzheimer disease (AD) and major depression... - Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADSLawrence S Mayer
Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA
Int J Geriatr Psychiatry 21:930-6. 2006..The pattern for the other subscales was non-monotonic over waves and resembled the pattern for the entire scale. Perhaps combining the CSDD two subscales obscures the treatment effects for the separate subscales... - Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County StudyConstantine G Lyketsos
Division of Geriatric Psychiatry and Neuropsychiatry, Dept of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Johns Hopkins Hospital, Baltimore, MD 21287, USA
Am J Geriatr Psychiatry 13:656-64. 2005..Authors investigated medical comorbidity in persons with dementia and "Cognitive Impairment, No Dementia" (CIND)... - Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County StudyPeter P Zandi
Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
Arch Gen Psychiatry 62:217-24. 2005..Prior reports suggest reduced occurrence of dementia and Alzheimer disease (AD) in statin users, but, to our knowledge, no prospective studies relate statin use and dementia incidence... - Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADSConstantine G Lyketsos
Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, Baltimore, MD, USA
Arch Gen Psychiatry 60:737-46. 2003..Results of prior antidepressant treatment studies have produced contradictory findings and have not fully assessed the benefits of depression reduction... - Falls and age in patients with Alzheimer's diseaseMedhat M Bassiony
Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
J Nerv Ment Dis 192:570-2. 2004..The authors conclude that falls in community-residing patients with AD are significantly associated with old age. Population-based prospective studies are needed to investigate further the risk factors for falls in AD... - Neuropsychiatric symptoms in dementia patients with and without a history of traumatic brain injuryVani Rao
Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry, Johns Hopkins University, Baltimore, MD 21224, USA
J Neuropsychiatry Clin Neurosci 22:166-72. 2010..7% versus 5.4%, OR=2.8, p=0.02), but not other neuropsychiatric symptoms. Traumatic brain injury may increase the risk of disinhibition in patients with dementia... - Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementiaJennifer L Payne
Neuropsychiatry Service, Department of Psychiatry and Behavioral Sciences, School of Medicine, The Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21287, USA
Int J Geriatr Psychiatry 17:247-53. 2002..Admission to a long-term care facility may actually result in a reduction of depression within the year after admission in part due to rapid recognition, appropriate diagnosis and treatment... - Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory StudyKatheen A Welsh-Bohmer
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA
Clin Neuropsychol 23:77-99. 2009..Among elderly without dementia or other cognitive impairment, APOE does not appear to exert any major effects on cognition once other demographic influences are controlled... - Amantadine for executive dysfunction syndrome in patients with dementiaShannon J Drayton
Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD 21287, USA
Psychosomatics 45:205-9. 2004..Despite its limitations, this study offers preliminary data to support a controlled trial of amantadine in patients with executive dysfunction syndrome... - Isolated hallucinosis in Alzheimer's disease is associated with African-American raceMedhat M Bassiony
Neuropsychiatry Service, Department of Psychiatry and Behavioral Science, School of Medicine, The Johns Hopkins University, USA
Int J Geriatr Psychiatry 17:205-10. 2002..This finding has implications for our understanding of the etio-pathogenesis of hallucinations in Alzheimer's disease and for meeting health service needs of African-American patients... - The relationship between delusions and depression in Alzheimer's diseaseMedhat M Bassiony
Department of Psychiatry, Faculty of Medicine, Zagazig University, Egypt
Int J Geriatr Psychiatry 17:549-56. 2002..This finding has implications for our understanding of the etio-pathogenesis and management of delusions and depression in AD... - Church attendance and new episodes of major depression in a community study of older adults: the Cache County StudyMaria C Norton
Department of Family, Consumer and Human Development, Cache County Study on Memory Health and Aging, Utah State University, 4440 Old Main Hill, Logan, UT 84322 4440, USA
J Gerontol B Psychol Sci Soc Sci 63:P129-37. 2008..28-0.92). Results suggest that there may be a threshold of church attendance that is necessary for a person to garner long-term protection from depression. We discuss sociological factors relevant to LDS culture... - Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxibBarbara K Martin
Arch Neurol 65:896-905. 2008..CONCLUSIONS: Use of naproxen or celecoxib did not improve cognitive function. There was weak evidence for a detrimental effect of naproxen... - Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County StudyKatherine A Treiber
Department of Psychology, Utah State University, Logan, U S A
Int Psychogeriatr 20:538-53. 2008..To examine, in an exploratory analysis, the association between vascular conditions and the occurrence of neuropsychiatric symptoms (NPS) in a population-based sample of incident Alzheimer's disease (AD)... - Pharmacological treatment of neuropsychiatric symptoms of dementiaMartin Steinberg
JAMA 293:2211-2; author reply 2212. 2005